nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—XDH—Doxorubicin—prostate cancer	0.0595	0.154	CbGbCtD
Trifluoperazine—CYP1A2—Flutamide—prostate cancer	0.0419	0.109	CbGbCtD
Trifluoperazine—ABCB1—Estramustine—prostate cancer	0.0411	0.107	CbGbCtD
Trifluoperazine—CYP1A2—Estrone—prostate cancer	0.0303	0.0785	CbGbCtD
Trifluoperazine—ABCB1—Cabazitaxel—prostate cancer	0.0271	0.0703	CbGbCtD
Trifluoperazine—ABCB1—Estrone—prostate cancer	0.0265	0.0687	CbGbCtD
Trifluoperazine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0236	0.0612	CbGbCtD
Trifluoperazine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0198	0.0514	CbGbCtD
Trifluoperazine—CYP1A2—Estradiol—prostate cancer	0.0174	0.0451	CbGbCtD
Trifluoperazine—ABCB1—Conjugated Estrogens—prostate cancer	0.0173	0.0449	CbGbCtD
Trifluoperazine—ABCB1—Mitoxantrone—prostate cancer	0.0157	0.0408	CbGbCtD
Trifluoperazine—ABCB1—Estradiol—prostate cancer	0.0152	0.0394	CbGbCtD
Trifluoperazine—ABCB1—Prednisone—prostate cancer	0.0131	0.0339	CbGbCtD
Trifluoperazine—CYP1A2—Etoposide—prostate cancer	0.0114	0.0294	CbGbCtD
Trifluoperazine—ABCB1—Etoposide—prostate cancer	0.00993	0.0258	CbGbCtD
Trifluoperazine—ABCB1—Docetaxel—prostate cancer	0.00909	0.0236	CbGbCtD
Trifluoperazine—ABCB1—Doxorubicin—prostate cancer	0.00677	0.0176	CbGbCtD
Trifluoperazine—EBPL—prostate gland—prostate cancer	0.00615	0.0522	CbGeAlD
Trifluoperazine—CALM2—semen—prostate cancer	0.00557	0.0474	CbGeAlD
Trifluoperazine—CALM1—semen—prostate cancer	0.00555	0.0471	CbGeAlD
Trifluoperazine—S100A4—prostate gland—prostate cancer	0.00485	0.0412	CbGeAlD
Trifluoperazine—EBPL—epithelium—prostate cancer	0.00452	0.0384	CbGeAlD
Trifluoperazine—S100A4—seminal vesicle—prostate cancer	0.0041	0.0349	CbGeAlD
Trifluoperazine—TNNC1—prostate gland—prostate cancer	0.00408	0.0347	CbGeAlD
Trifluoperazine—S100A4—epithelium—prostate cancer	0.00357	0.0303	CbGeAlD
Trifluoperazine—S100A4—renal system—prostate cancer	0.00331	0.0281	CbGeAlD
Trifluoperazine—S100A4—urethra—prostate cancer	0.00325	0.0276	CbGeAlD
Trifluoperazine—XDH—prostate gland—prostate cancer	0.00311	0.0264	CbGeAlD
Trifluoperazine—CYP1A2—urine—prostate cancer	0.00302	0.0256	CbGeAlD
Trifluoperazine—UGT1A4—renal system—prostate cancer	0.0029	0.0247	CbGeAlD
Trifluoperazine—EBPL—testis—prostate cancer	0.00271	0.023	CbGeAlD
Trifluoperazine—S100A4—bone marrow—prostate cancer	0.0025	0.0213	CbGeAlD
Trifluoperazine—CALY—testis—prostate cancer	0.00248	0.021	CbGeAlD
Trifluoperazine—HTR2A—urine—prostate cancer	0.00236	0.0201	CbGeAlD
Trifluoperazine—S100A4—testis—prostate cancer	0.00214	0.0182	CbGeAlD
Trifluoperazine—XDH—renal system—prostate cancer	0.00212	0.018	CbGeAlD
Trifluoperazine—EBPL—lymph node—prostate cancer	0.00196	0.0167	CbGeAlD
Trifluoperazine—TNNC1—testis—prostate cancer	0.0018	0.0153	CbGeAlD
Trifluoperazine—CALY—lymph node—prostate cancer	0.00179	0.0153	CbGeAlD
Trifluoperazine—CALM3—prostate gland—prostate cancer	0.00178	0.0151	CbGeAlD
Trifluoperazine—CHRM2—prostate gland—prostate cancer	0.00175	0.0149	CbGeAlD
Trifluoperazine—SIGMAR1—prostate gland—prostate cancer	0.00159	0.0135	CbGeAlD
Trifluoperazine—S100A4—lymph node—prostate cancer	0.00155	0.0132	CbGeAlD
Trifluoperazine—CALM3—seminal vesicle—prostate cancer	0.0015	0.0128	CbGeAlD
Trifluoperazine—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.0015	0.534	CbGdCrCtD
Trifluoperazine—CALM2—prostate gland—prostate cancer	0.0014	0.0119	CbGeAlD
Trifluoperazine—CALM1—prostate gland—prostate cancer	0.00139	0.0118	CbGeAlD
Trifluoperazine—SIGMAR1—seminal vesicle—prostate cancer	0.00134	0.0114	CbGeAlD
Trifluoperazine—ADRA1A—prostate gland—prostate cancer	0.00131	0.0111	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Prednisone—prostate cancer	0.00131	0.467	CbGdCrCtD
Trifluoperazine—TNNC1—lymph node—prostate cancer	0.0013	0.0111	CbGeAlD
Trifluoperazine—CALM3—urethra—prostate cancer	0.00119	0.0101	CbGeAlD
Trifluoperazine—CALM2—seminal vesicle—prostate cancer	0.00118	0.01	CbGeAlD
Trifluoperazine—SIGMAR1—urethra—prostate cancer	0.00106	0.00905	CbGeAlD
Trifluoperazine—CALM2—epithelium—prostate cancer	0.00103	0.00872	CbGeAlD
Trifluoperazine—CALM1—epithelium—prostate cancer	0.00102	0.00868	CbGeAlD
Trifluoperazine—HRH1—prostate gland—prostate cancer	0.00101	0.00862	CbGeAlD
Trifluoperazine—HTR1A—renal system—prostate cancer	0.000969	0.00823	CbGeAlD
Trifluoperazine—ADRA1A—epithelium—prostate cancer	0.000963	0.00818	CbGeAlD
Trifluoperazine—CALM2—renal system—prostate cancer	0.000952	0.00809	CbGeAlD
Trifluoperazine—CALM1—renal system—prostate cancer	0.000948	0.00805	CbGeAlD
Trifluoperazine—CALM2—urethra—prostate cancer	0.000935	0.00795	CbGeAlD
Trifluoperazine—CALM1—urethra—prostate cancer	0.000931	0.00791	CbGeAlD
Trifluoperazine—CALM3—bone marrow—prostate cancer	0.000917	0.00779	CbGeAlD
Trifluoperazine—ADRA1A—renal system—prostate cancer	0.000893	0.00759	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—prostate cancer	0.000819	0.00696	CbGeAlD
Trifluoperazine—CALM3—testis—prostate cancer	0.000784	0.00666	CbGeAlD
Trifluoperazine—HRH1—epithelium—prostate cancer	0.000745	0.00633	CbGeAlD
Trifluoperazine—CYP1A2—renal system—prostate cancer	0.000738	0.00628	CbGeAlD
Trifluoperazine—CALM2—bone marrow—prostate cancer	0.00072	0.00612	CbGeAlD
Trifluoperazine—CALM1—bone marrow—prostate cancer	0.000716	0.00609	CbGeAlD
Trifluoperazine—SIGMAR1—testis—prostate cancer	0.0007	0.00595	CbGeAlD
Trifluoperazine—HRH1—urethra—prostate cancer	0.000679	0.00577	CbGeAlD
Trifluoperazine—HTR2A—epithelium—prostate cancer	0.000622	0.00529	CbGeAlD
Trifluoperazine—CALM2—testis—prostate cancer	0.000615	0.00523	CbGeAlD
Trifluoperazine—CALM1—testis—prostate cancer	0.000612	0.00521	CbGeAlD
Trifluoperazine—HTR2A—renal system—prostate cancer	0.000577	0.00491	CbGeAlD
Trifluoperazine—CALM3—lymph node—prostate cancer	0.000568	0.00483	CbGeAlD
Trifluoperazine—DRD2—testis—prostate cancer	0.000566	0.00481	CbGeAlD
Trifluoperazine—ABCB1—prostate gland—prostate cancer	0.000555	0.00472	CbGeAlD
Trifluoperazine—SIGMAR1—lymph node—prostate cancer	0.000508	0.00431	CbGeAlD
Trifluoperazine—ABCB1—seminal vesicle—prostate cancer	0.000469	0.00399	CbGeAlD
Trifluoperazine—Perphenazine—AOX1—prostate cancer	0.000465	0.086	CrCbGaD
Trifluoperazine—HRH1—testis—prostate cancer	0.000447	0.0038	CbGeAlD
Trifluoperazine—CALM2—lymph node—prostate cancer	0.000446	0.00379	CbGeAlD
Trifluoperazine—CALM1—lymph node—prostate cancer	0.000444	0.00377	CbGeAlD
Trifluoperazine—ABCB1—epithelium—prostate cancer	0.000408	0.00347	CbGeAlD
Trifluoperazine—ABCB1—renal system—prostate cancer	0.000378	0.00322	CbGeAlD
Trifluoperazine—HTR2A—testis—prostate cancer	0.000373	0.00317	CbGeAlD
Trifluoperazine—ABCB1—urethra—prostate cancer	0.000372	0.00316	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—prostate cancer	0.000331	0.0613	CrCbGaD
Trifluoperazine—HRH1—lymph node—prostate cancer	0.000324	0.00275	CbGeAlD
Trifluoperazine—ABCB1—bone marrow—prostate cancer	0.000286	0.00243	CbGeAlD
Trifluoperazine—Acepromazine—SLC22A1—prostate cancer	0.000258	0.0478	CrCbGaD
Trifluoperazine—Thioproperazine—SLC22A1—prostate cancer	0.000253	0.0467	CrCbGaD
Trifluoperazine—Pipotiazine—SLC22A1—prostate cancer	0.000248	0.046	CrCbGaD
Trifluoperazine—Thiothixene—SLC22A1—prostate cancer	0.000248	0.046	CrCbGaD
Trifluoperazine—ABCB1—testis—prostate cancer	0.000245	0.00208	CbGeAlD
Trifluoperazine—Nefazodone—CYP3A5—prostate cancer	0.000231	0.0428	CrCbGaD
Trifluoperazine—Trazodone—CYP3A5—prostate cancer	0.000214	0.0396	CrCbGaD
Trifluoperazine—Clomipramine—GSTP1—prostate cancer	0.000212	0.0393	CrCbGaD
Trifluoperazine—Perphenazine—CYP2C18—prostate cancer	0.000208	0.0385	CrCbGaD
Trifluoperazine—Rash—Ethinyl Estradiol—prostate cancer	0.000204	0.00088	CcSEcCtD
Trifluoperazine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000204	0.000879	CcSEcCtD
Trifluoperazine—Headache—Ethinyl Estradiol—prostate cancer	0.000203	0.000874	CcSEcCtD
Trifluoperazine—Jaundice—Capecitabine—prostate cancer	0.000201	0.000867	CcSEcCtD
Trifluoperazine—Agranulocytosis—Docetaxel—prostate cancer	0.000199	0.000858	CcSEcCtD
Trifluoperazine—Increased appetite—Epirubicin—prostate cancer	0.000198	0.000856	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000198	0.000853	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000197	0.000848	CcSEcCtD
Trifluoperazine—Photosensitivity—Doxorubicin—prostate cancer	0.000196	0.000848	CcSEcCtD
Trifluoperazine—Hypersensitivity—Goserelin—prostate cancer	0.000196	0.000846	CcSEcCtD
Trifluoperazine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000194	0.000838	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000193	0.000831	CcSEcCtD
Trifluoperazine—Muscle spasms—Etoposide—prostate cancer	0.000193	0.000831	CcSEcCtD
Trifluoperazine—Agranulocytosis—Capecitabine—prostate cancer	0.000192	0.00083	CcSEcCtD
Trifluoperazine—Nausea—Ethinyl Estradiol—prostate cancer	0.000192	0.000829	CcSEcCtD
Trifluoperazine—Eczema—Doxorubicin—prostate cancer	0.000192	0.000828	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Epirubicin—prostate cancer	0.000191	0.000824	CcSEcCtD
Trifluoperazine—Asthenia—Goserelin—prostate cancer	0.000191	0.000824	CcSEcCtD
Trifluoperazine—Skin disorder—Mitoxantrone—prostate cancer	0.000191	0.000824	CcSEcCtD
Trifluoperazine—Insomnia—Estradiol—prostate cancer	0.000191	0.000823	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Prednisone—prostate cancer	0.00019	0.000819	CcSEcCtD
Trifluoperazine—Asthenia—Conjugated Estrogens—prostate cancer	0.000189	0.000816	CcSEcCtD
Trifluoperazine—Oedema peripheral—Docetaxel—prostate cancer	0.000188	0.000813	CcSEcCtD
Trifluoperazine—Pruritus—Goserelin—prostate cancer	0.000188	0.000812	CcSEcCtD
Trifluoperazine—Dyspnoea—Estradiol—prostate cancer	0.000188	0.000811	CcSEcCtD
Trifluoperazine—Somnolence—Estradiol—prostate cancer	0.000188	0.000809	CcSEcCtD
Trifluoperazine—Weight increased—Prednisone—prostate cancer	0.000188	0.000809	CcSEcCtD
Trifluoperazine—Anorexia—Mitoxantrone—prostate cancer	0.000187	0.000808	CcSEcCtD
Trifluoperazine—Pruritus—Conjugated Estrogens—prostate cancer	0.000186	0.000804	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Prednisone—prostate cancer	0.000186	0.000802	CcSEcCtD
Trifluoperazine—Hypotension—Mitoxantrone—prostate cancer	0.000184	0.000792	CcSEcCtD
Trifluoperazine—Increased appetite—Doxorubicin—prostate cancer	0.000184	0.000792	CcSEcCtD
Trifluoperazine—Decreased appetite—Estradiol—prostate cancer	0.000183	0.000791	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000183	0.000789	CcSEcCtD
Trifluoperazine—Oedema peripheral—Capecitabine—prostate cancer	0.000182	0.000787	CcSEcCtD
Trifluoperazine—Fatigue—Estradiol—prostate cancer	0.000182	0.000785	CcSEcCtD
Trifluoperazine—Constipation—Estradiol—prostate cancer	0.00018	0.000778	CcSEcCtD
Trifluoperazine—Leukopenia—Etoposide—prostate cancer	0.000179	0.000774	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000178	0.000769	CcSEcCtD
Trifluoperazine—Cardiac arrest—Epirubicin—prostate cancer	0.000177	0.000765	CcSEcCtD
Trifluoperazine—ABCB1—lymph node—prostate cancer	0.000177	0.00151	CbGeAlD
Trifluoperazine—Hypoglycaemia—Doxorubicin—prostate cancer	0.000177	0.000763	CcSEcCtD
Trifluoperazine—Dizziness—Goserelin—prostate cancer	0.000176	0.000759	CcSEcCtD
Trifluoperazine—Dyspnoea—Mitoxantrone—prostate cancer	0.000175	0.000756	CcSEcCtD
Trifluoperazine—Cough—Etoposide—prostate cancer	0.000175	0.000754	CcSEcCtD
Trifluoperazine—Somnolence—Mitoxantrone—prostate cancer	0.000175	0.000754	CcSEcCtD
Trifluoperazine—Dizziness—Conjugated Estrogens—prostate cancer	0.000174	0.000752	CcSEcCtD
Trifluoperazine—Convulsion—Etoposide—prostate cancer	0.000174	0.000749	CcSEcCtD
Trifluoperazine—Decreased appetite—Mitoxantrone—prostate cancer	0.000171	0.000737	CcSEcCtD
Trifluoperazine—Fatigue—Mitoxantrone—prostate cancer	0.000169	0.000731	CcSEcCtD
Trifluoperazine—Constipation—Mitoxantrone—prostate cancer	0.000168	0.000725	CcSEcCtD
Trifluoperazine—Rash—Goserelin—prostate cancer	0.000168	0.000724	CcSEcCtD
Trifluoperazine—Dermatitis—Goserelin—prostate cancer	0.000168	0.000723	CcSEcCtD
Trifluoperazine—Urticaria—Estradiol—prostate cancer	0.000168	0.000723	CcSEcCtD
Trifluoperazine—Body temperature increased—Estradiol—prostate cancer	0.000167	0.000719	CcSEcCtD
Trifluoperazine—Headache—Goserelin—prostate cancer	0.000167	0.000719	CcSEcCtD
Trifluoperazine—Erythema—Docetaxel—prostate cancer	0.000166	0.000718	CcSEcCtD
Trifluoperazine—Rash—Conjugated Estrogens—prostate cancer	0.000166	0.000717	CcSEcCtD
Trifluoperazine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000166	0.000716	CcSEcCtD
Trifluoperazine—Headache—Conjugated Estrogens—prostate cancer	0.000165	0.000712	CcSEcCtD
Trifluoperazine—Muscular weakness—Epirubicin—prostate cancer	0.000164	0.000709	CcSEcCtD
Trifluoperazine—Cardiac arrest—Doxorubicin—prostate cancer	0.000164	0.000708	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Etoposide—prostate cancer	0.000163	0.000705	CcSEcCtD
Trifluoperazine—Erythema—Capecitabine—prostate cancer	0.000161	0.000695	CcSEcCtD
Trifluoperazine—Dysphagia—Epirubicin—prostate cancer	0.000161	0.000695	CcSEcCtD
Trifluoperazine—Asthma—Epirubicin—prostate cancer	0.000161	0.000695	CcSEcCtD
Trifluoperazine—Muscle spasms—Docetaxel—prostate cancer	0.00016	0.000691	CcSEcCtD
Trifluoperazine—Eosinophilia—Epirubicin—prostate cancer	0.00016	0.000688	CcSEcCtD
Trifluoperazine—Skin disorder—Etoposide—prostate cancer	0.000159	0.000685	CcSEcCtD
Trifluoperazine—Nausea—Goserelin—prostate cancer	0.000158	0.000682	CcSEcCtD
Trifluoperazine—Nausea—Conjugated Estrogens—prostate cancer	0.000157	0.000675	CcSEcCtD
Trifluoperazine—Urticaria—Mitoxantrone—prostate cancer	0.000156	0.000674	CcSEcCtD
Trifluoperazine—Anorexia—Etoposide—prostate cancer	0.000156	0.000672	CcSEcCtD
Trifluoperazine—Hypersensitivity—Estradiol—prostate cancer	0.000155	0.00067	CcSEcCtD
Trifluoperazine—Body temperature increased—Mitoxantrone—prostate cancer	0.000155	0.00067	CcSEcCtD
Trifluoperazine—Muscle spasms—Capecitabine—prostate cancer	0.000155	0.000669	CcSEcCtD
Trifluoperazine—Pancytopenia—Epirubicin—prostate cancer	0.000153	0.00066	CcSEcCtD
Trifluoperazine—Hypotension—Etoposide—prostate cancer	0.000153	0.000659	CcSEcCtD
Trifluoperazine—Muscular weakness—Doxorubicin—prostate cancer	0.000152	0.000656	CcSEcCtD
Trifluoperazine—Vision blurred—Capecitabine—prostate cancer	0.000152	0.000655	CcSEcCtD
Trifluoperazine—Asthenia—Estradiol—prostate cancer	0.000151	0.000653	CcSEcCtD
Trifluoperazine—Tremor—Capecitabine—prostate cancer	0.000151	0.000652	CcSEcCtD
Trifluoperazine—Pruritus—Estradiol—prostate cancer	0.000149	0.000644	CcSEcCtD
Trifluoperazine—Asthma—Doxorubicin—prostate cancer	0.000149	0.000643	CcSEcCtD
Trifluoperazine—Dysphagia—Doxorubicin—prostate cancer	0.000149	0.000643	CcSEcCtD
Trifluoperazine—Leukopenia—Docetaxel—prostate cancer	0.000149	0.000643	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—prostate cancer	0.000148	0.000637	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Epirubicin—prostate cancer	0.000147	0.000635	CcSEcCtD
Trifluoperazine—Weight increased—Epirubicin—prostate cancer	0.000147	0.000633	CcSEcCtD
Trifluoperazine—Dyspnoea—Etoposide—prostate cancer	0.000146	0.000629	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Epirubicin—prostate cancer	0.000145	0.000627	CcSEcCtD
Trifluoperazine—Somnolence—Etoposide—prostate cancer	0.000145	0.000627	CcSEcCtD
Trifluoperazine—Cough—Docetaxel—prostate cancer	0.000145	0.000627	CcSEcCtD
Trifluoperazine—Clozapine—CYP1B1—prostate cancer	0.000145	0.0269	CrCbGaD
Trifluoperazine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000145	0.000625	CcSEcCtD
Trifluoperazine—Leukopenia—Capecitabine—prostate cancer	0.000144	0.000622	CcSEcCtD
Trifluoperazine—Convulsion—Docetaxel—prostate cancer	0.000144	0.000622	CcSEcCtD
Trifluoperazine—Drowsiness—Epirubicin—prostate cancer	0.000144	0.00062	CcSEcCtD
Trifluoperazine—Erythema—Prednisone—prostate cancer	0.000144	0.000619	CcSEcCtD
Trifluoperazine—Decreased appetite—Etoposide—prostate cancer	0.000142	0.000613	CcSEcCtD
Trifluoperazine—Alimemazine—CYP3A4—prostate cancer	0.000142	0.0262	CrCbGaD
Trifluoperazine—Pancytopenia—Doxorubicin—prostate cancer	0.000142	0.000611	CcSEcCtD
Trifluoperazine—Asthenia—Mitoxantrone—prostate cancer	0.000141	0.000608	CcSEcCtD
Trifluoperazine—Fatigue—Etoposide—prostate cancer	0.000141	0.000608	CcSEcCtD
Trifluoperazine—Cough—Capecitabine—prostate cancer	0.000141	0.000607	CcSEcCtD
Trifluoperazine—Jaundice—Epirubicin—prostate cancer	0.00014	0.000604	CcSEcCtD
Trifluoperazine—Constipation—Etoposide—prostate cancer	0.00014	0.000603	CcSEcCtD
Trifluoperazine—Dizziness—Estradiol—prostate cancer	0.000139	0.000602	CcSEcCtD
Trifluoperazine—Dry mouth—Docetaxel—prostate cancer	0.000139	0.000598	CcSEcCtD
Trifluoperazine—Pipotiazine—CYP2C19—prostate cancer	0.000136	0.0253	CrCbGaD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000136	0.000587	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Docetaxel—prostate cancer	0.000136	0.000586	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—prostate cancer	0.000136	0.000585	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisone—prostate cancer	0.000135	0.000584	CcSEcCtD
Trifluoperazine—Chlorpromazine—SLC22A1—prostate cancer	0.000135	0.0249	CrCbGaD
Trifluoperazine—Hyperglycaemia—Doxorubicin—prostate cancer	0.000135	0.00058	CcSEcCtD
Trifluoperazine—Quetiapine—CYP3A5—prostate cancer	0.000134	0.0249	CrCbGaD
Trifluoperazine—Dry mouth—Capecitabine—prostate cancer	0.000134	0.000579	CcSEcCtD
Trifluoperazine—Agranulocytosis—Epirubicin—prostate cancer	0.000134	0.000579	CcSEcCtD
Trifluoperazine—Rash—Estradiol—prostate cancer	0.000133	0.000574	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—prostate cancer	0.000133	0.000574	CcSEcCtD
Trifluoperazine—Dermatitis—Estradiol—prostate cancer	0.000133	0.000573	CcSEcCtD
Trifluoperazine—Headache—Estradiol—prostate cancer	0.000132	0.00057	CcSEcCtD
Trifluoperazine—Skin disorder—Docetaxel—prostate cancer	0.000132	0.000569	CcSEcCtD
Trifluoperazine—Agitation—Prednisone—prostate cancer	0.000132	0.000569	CcSEcCtD
Trifluoperazine—Angioedema—Prednisone—prostate cancer	0.000131	0.000566	CcSEcCtD
Trifluoperazine—Urticaria—Etoposide—prostate cancer	0.00013	0.00056	CcSEcCtD
Trifluoperazine—Jaundice—Doxorubicin—prostate cancer	0.00013	0.000559	CcSEcCtD
Trifluoperazine—Anorexia—Docetaxel—prostate cancer	0.00013	0.000559	CcSEcCtD
Trifluoperazine—Body temperature increased—Etoposide—prostate cancer	0.000129	0.000558	CcSEcCtD
Trifluoperazine—Skin disorder—Capecitabine—prostate cancer	0.000128	0.000551	CcSEcCtD
Trifluoperazine—Oedema peripheral—Epirubicin—prostate cancer	0.000127	0.000548	CcSEcCtD
Trifluoperazine—Hypotension—Docetaxel—prostate cancer	0.000127	0.000548	CcSEcCtD
Trifluoperazine—Anorexia—Capecitabine—prostate cancer	0.000125	0.000541	CcSEcCtD
Trifluoperazine—Nausea—Estradiol—prostate cancer	0.000125	0.000541	CcSEcCtD
Trifluoperazine—Convulsion—Prednisone—prostate cancer	0.000124	0.000537	CcSEcCtD
Trifluoperazine—Agranulocytosis—Doxorubicin—prostate cancer	0.000124	0.000535	CcSEcCtD
Trifluoperazine—Rash—Mitoxantrone—prostate cancer	0.000124	0.000535	CcSEcCtD
Trifluoperazine—Dermatitis—Mitoxantrone—prostate cancer	0.000124	0.000534	CcSEcCtD
Trifluoperazine—Headache—Mitoxantrone—prostate cancer	0.000123	0.000531	CcSEcCtD
Trifluoperazine—Hypotension—Capecitabine—prostate cancer	0.000123	0.00053	CcSEcCtD
Trifluoperazine—Insomnia—Docetaxel—prostate cancer	0.000123	0.00053	CcSEcCtD
Trifluoperazine—Mequitazine—CYP3A4—prostate cancer	0.000122	0.0226	CrCbGaD
Trifluoperazine—Dyspnoea—Docetaxel—prostate cancer	0.000121	0.000523	CcSEcCtD
Trifluoperazine—Somnolence—Docetaxel—prostate cancer	0.000121	0.000521	CcSEcCtD
Trifluoperazine—Hypersensitivity—Etoposide—prostate cancer	0.00012	0.00052	CcSEcCtD
Trifluoperazine—Fluphenazine—CYP2E1—prostate cancer	0.000119	0.022	CrCbGaD
Trifluoperazine—Insomnia—Capecitabine—prostate cancer	0.000119	0.000513	CcSEcCtD
Trifluoperazine—Decreased appetite—Docetaxel—prostate cancer	0.000118	0.00051	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—prostate cancer	0.000118	0.000507	CcSEcCtD
Trifluoperazine—Asthenia—Etoposide—prostate cancer	0.000117	0.000506	CcSEcCtD
Trifluoperazine—Dyspnoea—Capecitabine—prostate cancer	0.000117	0.000506	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisone—prostate cancer	0.000117	0.000506	CcSEcCtD
Trifluoperazine—Fatigue—Docetaxel—prostate cancer	0.000117	0.000505	CcSEcCtD
Trifluoperazine—Nausea—Mitoxantrone—prostate cancer	0.000117	0.000504	CcSEcCtD
Trifluoperazine—Constipation—Docetaxel—prostate cancer	0.000116	0.000501	CcSEcCtD
Trifluoperazine—Pruritus—Etoposide—prostate cancer	0.000116	0.000499	CcSEcCtD
Trifluoperazine—Decreased appetite—Capecitabine—prostate cancer	0.000114	0.000493	CcSEcCtD
Trifluoperazine—Skin disorder—Prednisone—prostate cancer	0.000114	0.000491	CcSEcCtD
Trifluoperazine—Fatigue—Capecitabine—prostate cancer	0.000113	0.000489	CcSEcCtD
Trifluoperazine—Constipation—Capecitabine—prostate cancer	0.000112	0.000485	CcSEcCtD
Trifluoperazine—Erythema—Epirubicin—prostate cancer	0.000112	0.000484	CcSEcCtD
Trifluoperazine—Clozapine—CYP2A6—prostate cancer	0.000112	0.0207	CrCbGaD
Trifluoperazine—Anorexia—Prednisone—prostate cancer	0.000112	0.000482	CcSEcCtD
Trifluoperazine—Nervousness—Epirubicin—prostate cancer	0.000109	0.000471	CcSEcCtD
Trifluoperazine—Dizziness—Etoposide—prostate cancer	0.000108	0.000466	CcSEcCtD
Trifluoperazine—Muscle spasms—Epirubicin—prostate cancer	0.000108	0.000466	CcSEcCtD
Trifluoperazine—Clomipramine—CYP2C19—prostate cancer	0.000108	0.02	CrCbGaD
Trifluoperazine—Body temperature increased—Docetaxel—prostate cancer	0.000107	0.000463	CcSEcCtD
Trifluoperazine—Insomnia—Prednisone—prostate cancer	0.000106	0.000457	CcSEcCtD
Trifluoperazine—Vision blurred—Epirubicin—prostate cancer	0.000106	0.000457	CcSEcCtD
Trifluoperazine—Urticaria—Capecitabine—prostate cancer	0.000105	0.000451	CcSEcCtD
Trifluoperazine—Body temperature increased—Capecitabine—prostate cancer	0.000104	0.000449	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—prostate cancer	0.000104	0.000448	CcSEcCtD
Trifluoperazine—Agitation—Epirubicin—prostate cancer	0.000103	0.000445	CcSEcCtD
Trifluoperazine—Rash—Etoposide—prostate cancer	0.000103	0.000445	CcSEcCtD
Trifluoperazine—Dermatitis—Etoposide—prostate cancer	0.000103	0.000444	CcSEcCtD
Trifluoperazine—Thioridazine—CYP2E1—prostate cancer	0.000103	0.019	CrCbGaD
Trifluoperazine—Headache—Etoposide—prostate cancer	0.000102	0.000442	CcSEcCtD
Trifluoperazine—Decreased appetite—Prednisone—prostate cancer	0.000102	0.000439	CcSEcCtD
Trifluoperazine—Thioridazine—CYP2C19—prostate cancer	0.000102	0.0188	CrCbGaD
Trifluoperazine—Fatigue—Prednisone—prostate cancer	0.000101	0.000436	CcSEcCtD
Trifluoperazine—Nervousness—Doxorubicin—prostate cancer	0.000101	0.000435	CcSEcCtD
Trifluoperazine—Leukopenia—Epirubicin—prostate cancer	0.000101	0.000434	CcSEcCtD
Trifluoperazine—Constipation—Prednisone—prostate cancer	0.0001	0.000432	CcSEcCtD
Trifluoperazine—Hypersensitivity—Docetaxel—prostate cancer	0.0001	0.000432	CcSEcCtD
Trifluoperazine—Nefazodone—CYP3A4—prostate cancer	0.0001	0.0185	CrCbGaD
Trifluoperazine—Muscle spasms—Doxorubicin—prostate cancer	9.99e-05	0.000431	CcSEcCtD
Trifluoperazine—Cough—Epirubicin—prostate cancer	9.8e-05	0.000423	CcSEcCtD
Trifluoperazine—Methotrimeprazine—CYP2E1—prostate cancer	9.8e-05	0.0181	CrCbGaD
Trifluoperazine—Vision blurred—Doxorubicin—prostate cancer	9.79e-05	0.000422	CcSEcCtD
Trifluoperazine—Asthenia—Docetaxel—prostate cancer	9.75e-05	0.000421	CcSEcCtD
Trifluoperazine—Convulsion—Epirubicin—prostate cancer	9.73e-05	0.00042	CcSEcCtD
Trifluoperazine—Nausea—Etoposide—prostate cancer	9.71e-05	0.000419	CcSEcCtD
Trifluoperazine—Hypersensitivity—Capecitabine—prostate cancer	9.69e-05	0.000418	CcSEcCtD
Trifluoperazine—Pruritus—Docetaxel—prostate cancer	9.61e-05	0.000415	CcSEcCtD
Trifluoperazine—Agitation—Doxorubicin—prostate cancer	9.55e-05	0.000412	CcSEcCtD
Trifluoperazine—Asthenia—Capecitabine—prostate cancer	9.44e-05	0.000407	CcSEcCtD
Trifluoperazine—Dry mouth—Epirubicin—prostate cancer	9.35e-05	0.000403	CcSEcCtD
Trifluoperazine—Perphenazine—CYP2C19—prostate cancer	9.33e-05	0.0173	CrCbGaD
Trifluoperazine—Urticaria—Prednisone—prostate cancer	9.31e-05	0.000402	CcSEcCtD
Trifluoperazine—Pruritus—Capecitabine—prostate cancer	9.31e-05	0.000402	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—prostate cancer	9.3e-05	0.000401	CcSEcCtD
Trifluoperazine—Body temperature increased—Prednisone—prostate cancer	9.26e-05	0.0004	CcSEcCtD
Trifluoperazine—Trazodone—CYP3A4—prostate cancer	9.26e-05	0.0171	CrCbGaD
Trifluoperazine—Anaphylactic shock—Epirubicin—prostate cancer	9.16e-05	0.000395	CcSEcCtD
Trifluoperazine—Quetiapine—CYP2C19—prostate cancer	9.15e-05	0.0169	CrCbGaD
Trifluoperazine—Cough—Doxorubicin—prostate cancer	9.07e-05	0.000391	CcSEcCtD
Trifluoperazine—Convulsion—Doxorubicin—prostate cancer	9e-05	0.000388	CcSEcCtD
Trifluoperazine—Dizziness—Docetaxel—prostate cancer	8.98e-05	0.000388	CcSEcCtD
Trifluoperazine—Skin disorder—Epirubicin—prostate cancer	8.9e-05	0.000384	CcSEcCtD
Trifluoperazine—Anorexia—Epirubicin—prostate cancer	8.74e-05	0.000377	CcSEcCtD
Trifluoperazine—Dizziness—Capecitabine—prostate cancer	8.7e-05	0.000375	CcSEcCtD
Trifluoperazine—Pipotiazine—CYP3A4—prostate cancer	8.68e-05	0.0161	CrCbGaD
Trifluoperazine—Dry mouth—Doxorubicin—prostate cancer	8.65e-05	0.000373	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisone—prostate cancer	8.63e-05	0.000372	CcSEcCtD
Trifluoperazine—Rash—Docetaxel—prostate cancer	8.57e-05	0.00037	CcSEcCtD
Trifluoperazine—Hypotension—Epirubicin—prostate cancer	8.56e-05	0.000369	CcSEcCtD
Trifluoperazine—Dermatitis—Docetaxel—prostate cancer	8.56e-05	0.000369	CcSEcCtD
Trifluoperazine—Headache—Docetaxel—prostate cancer	8.51e-05	0.000367	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—prostate cancer	8.48e-05	0.000366	CcSEcCtD
Trifluoperazine—Promazine—CYP2C19—prostate cancer	8.41e-05	0.0156	CrCbGaD
Trifluoperazine—Asthenia—Prednisone—prostate cancer	8.41e-05	0.000363	CcSEcCtD
Trifluoperazine—Rash—Capecitabine—prostate cancer	8.29e-05	0.000358	CcSEcCtD
Trifluoperazine—Prochlorperazine—CYP3A4—prostate cancer	8.29e-05	0.0153	CrCbGaD
Trifluoperazine—Pruritus—Prednisone—prostate cancer	8.29e-05	0.000358	CcSEcCtD
Trifluoperazine—Insomnia—Epirubicin—prostate cancer	8.29e-05	0.000358	CcSEcCtD
Trifluoperazine—Dermatitis—Capecitabine—prostate cancer	8.29e-05	0.000358	CcSEcCtD
Trifluoperazine—Headache—Capecitabine—prostate cancer	8.24e-05	0.000356	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—prostate cancer	8.24e-05	0.000355	CcSEcCtD
Trifluoperazine—Dyspnoea—Epirubicin—prostate cancer	8.17e-05	0.000352	CcSEcCtD
Trifluoperazine—Somnolence—Epirubicin—prostate cancer	8.15e-05	0.000351	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—prostate cancer	8.08e-05	0.000349	CcSEcCtD
Trifluoperazine—Nausea—Docetaxel—prostate cancer	8.07e-05	0.000348	CcSEcCtD
Trifluoperazine—Decreased appetite—Epirubicin—prostate cancer	7.97e-05	0.000344	CcSEcCtD
Trifluoperazine—Clozapine—CYP2E1—prostate cancer	7.94e-05	0.0147	CrCbGaD
Trifluoperazine—Hypotension—Doxorubicin—prostate cancer	7.92e-05	0.000342	CcSEcCtD
Trifluoperazine—Fatigue—Epirubicin—prostate cancer	7.9e-05	0.000341	CcSEcCtD
Trifluoperazine—Clozapine—CYP2C19—prostate cancer	7.87e-05	0.0146	CrCbGaD
Trifluoperazine—Constipation—Epirubicin—prostate cancer	7.84e-05	0.000338	CcSEcCtD
Trifluoperazine—Clozapine—CYP1A1—prostate cancer	7.84e-05	0.0145	CrCbGaD
Trifluoperazine—Nausea—Capecitabine—prostate cancer	7.81e-05	0.000337	CcSEcCtD
Trifluoperazine—Dizziness—Prednisone—prostate cancer	7.75e-05	0.000334	CcSEcCtD
Trifluoperazine—Insomnia—Doxorubicin—prostate cancer	7.67e-05	0.000331	CcSEcCtD
Trifluoperazine—Dyspnoea—Doxorubicin—prostate cancer	7.56e-05	0.000326	CcSEcCtD
Trifluoperazine—Somnolence—Doxorubicin—prostate cancer	7.54e-05	0.000325	CcSEcCtD
Trifluoperazine—Chlorpromazine—CYP2E1—prostate cancer	7.47e-05	0.0138	CrCbGaD
Trifluoperazine—Rash—Prednisone—prostate cancer	7.39e-05	0.000319	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisone—prostate cancer	7.38e-05	0.000318	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—prostate cancer	7.37e-05	0.000318	CcSEcCtD
Trifluoperazine—Headache—Prednisone—prostate cancer	7.34e-05	0.000317	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—prostate cancer	7.31e-05	0.000315	CcSEcCtD
Trifluoperazine—Urticaria—Epirubicin—prostate cancer	7.28e-05	0.000314	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—prostate cancer	7.25e-05	0.000313	CcSEcCtD
Trifluoperazine—Body temperature increased—Epirubicin—prostate cancer	7.24e-05	0.000313	CcSEcCtD
Trifluoperazine—Nausea—Prednisone—prostate cancer	6.96e-05	0.0003	CcSEcCtD
Trifluoperazine—Clomipramine—CYP3A4—prostate cancer	6.86e-05	0.0127	CrCbGaD
Trifluoperazine—Hypersensitivity—Epirubicin—prostate cancer	6.75e-05	0.000291	CcSEcCtD
Trifluoperazine—Urticaria—Doxorubicin—prostate cancer	6.74e-05	0.000291	CcSEcCtD
Trifluoperazine—Body temperature increased—Doxorubicin—prostate cancer	6.7e-05	0.000289	CcSEcCtD
Trifluoperazine—Asthenia—Epirubicin—prostate cancer	6.58e-05	0.000284	CcSEcCtD
Trifluoperazine—Pruritus—Epirubicin—prostate cancer	6.48e-05	0.00028	CcSEcCtD
Trifluoperazine—Hypersensitivity—Doxorubicin—prostate cancer	6.25e-05	0.00027	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—prostate cancer	6.08e-05	0.000262	CcSEcCtD
Trifluoperazine—Dizziness—Epirubicin—prostate cancer	6.06e-05	0.000261	CcSEcCtD
Trifluoperazine—Pruritus—Doxorubicin—prostate cancer	6e-05	0.000259	CcSEcCtD
Trifluoperazine—Perphenazine—CYP3A4—prostate cancer	5.93e-05	0.011	CrCbGaD
Trifluoperazine—Quetiapine—CYP3A4—prostate cancer	5.82e-05	0.0108	CrCbGaD
Trifluoperazine—Rash—Epirubicin—prostate cancer	5.78e-05	0.000249	CcSEcCtD
Trifluoperazine—Dermatitis—Epirubicin—prostate cancer	5.77e-05	0.000249	CcSEcCtD
Trifluoperazine—Headache—Epirubicin—prostate cancer	5.74e-05	0.000248	CcSEcCtD
Trifluoperazine—Dizziness—Doxorubicin—prostate cancer	5.61e-05	0.000242	CcSEcCtD
Trifluoperazine—Nausea—Epirubicin—prostate cancer	5.44e-05	0.000235	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—prostate cancer	5.35e-05	0.000231	CcSEcCtD
Trifluoperazine—Promazine—CYP3A4—prostate cancer	5.35e-05	0.00989	CrCbGaD
Trifluoperazine—Dermatitis—Doxorubicin—prostate cancer	5.34e-05	0.00023	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—prostate cancer	5.31e-05	0.000229	CcSEcCtD
Trifluoperazine—Nausea—Doxorubicin—prostate cancer	5.04e-05	0.000217	CcSEcCtD
Trifluoperazine—Clozapine—CYP3A4—prostate cancer	5e-05	0.00926	CrCbGaD
Trifluoperazine—Chlorpromazine—CYP3A4—prostate cancer	4.71e-05	0.00871	CrCbGaD
Trifluoperazine—CALM2—Immune System—EGFR—prostate cancer	1.93e-06	7.5e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—prostate cancer	1.93e-06	7.5e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.92e-06	7.49e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—prostate cancer	1.92e-06	7.48e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—prostate cancer	1.92e-06	7.48e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.92e-06	7.47e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.92e-06	7.47e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.91e-06	7.46e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.91e-06	7.45e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.91e-06	7.43e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.91e-06	7.43e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.91e-06	7.42e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.9e-06	7.41e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAV1—prostate cancer	1.9e-06	7.4e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTEN—prostate cancer	1.89e-06	7.38e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.89e-06	7.37e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PIK3CA—prostate cancer	1.89e-06	7.37e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.88e-06	7.34e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MDM2—prostate cancer	1.88e-06	7.34e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KRAS—prostate cancer	1.88e-06	7.33e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—prostate cancer	1.88e-06	7.32e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.88e-06	7.32e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.88e-06	7.31e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—prostate cancer	1.87e-06	7.3e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.87e-06	7.3e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.87e-06	7.29e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.87e-06	7.28e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JAK2—prostate cancer	1.87e-06	7.27e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JAK2—prostate cancer	1.87e-06	7.27e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—prostate cancer	1.86e-06	7.26e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.86e-06	7.25e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.86e-06	7.23e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—prostate cancer	1.86e-06	7.23e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EP300—prostate cancer	1.85e-06	7.2e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—prostate cancer	1.84e-06	7.16e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—prostate cancer	1.84e-06	7.15e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CB—prostate cancer	1.83e-06	7.14e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTEN—prostate cancer	1.83e-06	7.14e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTEN—prostate cancer	1.83e-06	7.14e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.83e-06	7.13e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—prostate cancer	1.83e-06	7.13e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—prostate cancer	1.83e-06	7.13e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.83e-06	7.12e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.83e-06	7.11e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.82e-06	7.1e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—prostate cancer	1.82e-06	7.1e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—prostate cancer	1.82e-06	7.1e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.82e-06	7.09e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—prostate cancer	1.82e-06	7.09e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—prostate cancer	1.82e-06	7.09e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EP300—prostate cancer	1.82e-06	7.09e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—prostate cancer	1.82e-06	7.08e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—prostate cancer	1.82e-06	7.08e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EP300—prostate cancer	1.82e-06	7.07e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.82e-06	7.07e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—prostate cancer	1.81e-06	7.06e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—prostate cancer	1.81e-06	7.06e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—EP300—prostate cancer	1.81e-06	7.04e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—prostate cancer	1.8e-06	7.01e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SRC—prostate cancer	1.8e-06	7e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—prostate cancer	1.8e-06	7e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—prostate cancer	1.8e-06	7e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.8e-06	6.99e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.79e-06	6.96e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.79e-06	6.96e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.78e-06	6.94e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—prostate cancer	1.78e-06	6.93e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—prostate cancer	1.78e-06	6.93e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CB—prostate cancer	1.77e-06	6.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CB—prostate cancer	1.77e-06	6.91e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SRC—prostate cancer	1.77e-06	6.89e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SRC—prostate cancer	1.77e-06	6.88e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL8—prostate cancer	1.76e-06	6.86e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.75e-06	6.82e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—EP300—prostate cancer	1.75e-06	6.81e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—EP300—prostate cancer	1.75e-06	6.81e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.74e-06	6.77e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—prostate cancer	1.74e-06	6.76e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.73e-06	6.75e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.73e-06	6.75e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.73e-06	6.74e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—prostate cancer	1.73e-06	6.73e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.72e-06	6.71e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1B—prostate cancer	1.72e-06	6.7e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.72e-06	6.7e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—prostate cancer	1.72e-06	6.7e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.71e-06	6.65e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL8—prostate cancer	1.7e-06	6.64e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL8—prostate cancer	1.7e-06	6.64e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.7e-06	6.63e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.7e-06	6.6e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.69e-06	6.59e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.69e-06	6.57e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.69e-06	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—prostate cancer	1.69e-06	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—prostate cancer	1.68e-06	6.56e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—prostate cancer	1.68e-06	6.54e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—prostate cancer	1.68e-06	6.54e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.68e-06	6.53e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—prostate cancer	1.67e-06	6.52e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—prostate cancer	1.67e-06	6.51e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—prostate cancer	1.67e-06	6.51e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.67e-06	6.51e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1B—prostate cancer	1.66e-06	6.48e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1B—prostate cancer	1.66e-06	6.48e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.66e-06	6.47e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—prostate cancer	1.65e-06	6.41e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—prostate cancer	1.64e-06	6.39e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—INS—prostate cancer	1.64e-06	6.38e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—prostate cancer	1.63e-06	6.35e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—prostate cancer	1.63e-06	6.35e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—prostate cancer	1.63e-06	6.34e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—prostate cancer	1.63e-06	6.34e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CTNNB1—prostate cancer	1.62e-06	6.33e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—prostate cancer	1.62e-06	6.31e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—prostate cancer	1.62e-06	6.31e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—prostate cancer	1.61e-06	6.28e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.61e-06	6.26e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.6e-06	6.25e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—prostate cancer	1.6e-06	6.21e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—prostate cancer	1.59e-06	6.2e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—prostate cancer	1.59e-06	6.18e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—prostate cancer	1.59e-06	6.18e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—prostate cancer	1.59e-06	6.18e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—prostate cancer	1.59e-06	6.18e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PTEN—prostate cancer	1.58e-06	6.17e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—prostate cancer	1.58e-06	6.16e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.58e-06	6.16e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.58e-06	6.15e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.58e-06	6.14e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CTNNB1—prostate cancer	1.57e-06	6.12e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CTNNB1—prostate cancer	1.57e-06	6.12e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.56e-06	6.07e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.56e-06	6.06e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.55e-06	6.05e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.55e-06	6.05e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.55e-06	6.04e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.55e-06	6.04e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.55e-06	6.03e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.55e-06	6.03e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—prostate cancer	1.55e-06	6.02e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—prostate cancer	1.54e-06	6.01e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—prostate cancer	1.54e-06	6.01e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—prostate cancer	1.54e-06	6e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—prostate cancer	1.54e-06	6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—prostate cancer	1.54e-06	5.98e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—prostate cancer	1.54e-06	5.98e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PTEN—prostate cancer	1.53e-06	5.97e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PTEN—prostate cancer	1.53e-06	5.97e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—prostate cancer	1.53e-06	5.96e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.52e-06	5.93e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.52e-06	5.93e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.52e-06	5.91e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EP300—prostate cancer	1.51e-06	5.88e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—prostate cancer	1.51e-06	5.87e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—prostate cancer	1.5e-06	5.84e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—prostate cancer	1.49e-06	5.82e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—prostate cancer	1.49e-06	5.82e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—prostate cancer	1.49e-06	5.8e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—prostate cancer	1.48e-06	5.77e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—prostate cancer	1.48e-06	5.77e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SRC—prostate cancer	1.47e-06	5.72e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.46e-06	5.71e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.46e-06	5.69e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EP300—prostate cancer	1.46e-06	5.69e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EP300—prostate cancer	1.46e-06	5.69e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.44e-06	5.6e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—prostate cancer	1.44e-06	5.6e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTEN—prostate cancer	1.44e-06	5.59e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.43e-06	5.59e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—prostate cancer	1.43e-06	5.57e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SRC—prostate cancer	1.42e-06	5.53e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SRC—prostate cancer	1.42e-06	5.53e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—prostate cancer	1.42e-06	5.52e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—prostate cancer	1.41e-06	5.5e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—prostate cancer	1.41e-06	5.5e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—prostate cancer	1.38e-06	5.39e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—prostate cancer	1.38e-06	5.39e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—prostate cancer	1.38e-06	5.37e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—prostate cancer	1.37e-06	5.35e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—prostate cancer	1.37e-06	5.34e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—prostate cancer	1.37e-06	5.34e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—EP300—prostate cancer	1.37e-06	5.33e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.37e-06	5.33e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—prostate cancer	1.37e-06	5.32e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—prostate cancer	1.37e-06	5.32e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—prostate cancer	1.37e-06	5.32e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—prostate cancer	1.37e-06	5.32e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	1.35e-06	5.24e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.34e-06	5.23e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—prostate cancer	1.34e-06	5.2e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.33e-06	5.16e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—prostate cancer	1.32e-06	5.15e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.32e-06	5.15e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	1.32e-06	5.13e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—prostate cancer	1.32e-06	5.13e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.31e-06	5.12e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—prostate cancer	1.31e-06	5.11e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—prostate cancer	1.3e-06	5.08e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—prostate cancer	1.3e-06	5.07e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—prostate cancer	1.3e-06	5.06e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—prostate cancer	1.29e-06	5.03e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—prostate cancer	1.29e-06	5.03e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—prostate cancer	1.29e-06	5.01e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—prostate cancer	1.28e-06	4.98e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—prostate cancer	1.27e-06	4.97e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—prostate cancer	1.27e-06	4.96e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—prostate cancer	1.27e-06	4.96e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.27e-06	4.96e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—prostate cancer	1.27e-06	4.95e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—prostate cancer	1.27e-06	4.95e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.27e-06	4.93e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—prostate cancer	1.26e-06	4.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—prostate cancer	1.26e-06	4.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—prostate cancer	1.25e-06	4.85e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—prostate cancer	1.25e-06	4.85e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—prostate cancer	1.22e-06	4.74e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—prostate cancer	1.21e-06	4.72e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—prostate cancer	1.19e-06	4.64e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—prostate cancer	1.19e-06	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—prostate cancer	1.18e-06	4.58e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—prostate cancer	1.18e-06	4.58e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—prostate cancer	1.17e-06	4.56e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—prostate cancer	1.17e-06	4.55e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTEN—prostate cancer	1.15e-06	4.46e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—prostate cancer	1.12e-06	4.35e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—prostate cancer	1.12e-06	4.35e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—prostate cancer	1.1e-06	4.28e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.1e-06	4.27e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—EP300—prostate cancer	1.09e-06	4.26e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—prostate cancer	1.09e-06	4.25e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—prostate cancer	1.08e-06	4.21e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—prostate cancer	1.08e-06	4.21e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—prostate cancer	1.08e-06	4.21e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—prostate cancer	1.08e-06	4.2e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	1.08e-06	4.19e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—prostate cancer	1.06e-06	4.11e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—prostate cancer	1.06e-06	4.11e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—prostate cancer	1.05e-06	4.07e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—prostate cancer	1.05e-06	4.07e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.01e-06	3.94e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—prostate cancer	9.89e-07	3.85e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—prostate cancer	9.57e-07	3.73e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—prostate cancer	9.57e-07	3.73e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—prostate cancer	9.13e-07	3.55e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—prostate cancer	8.83e-07	3.44e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—prostate cancer	8.83e-07	3.44e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—prostate cancer	8.27e-07	3.22e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.08e-07	3.15e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—prostate cancer	6.6e-07	2.57e-06	CbGpPWpGaD
